Pharmatec Engineering ApS: Financial statements 2025
CVR: 37819859
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharmatec Engineering ApS (CVR 37819859) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,380,062 and a net result of DKK 2,278,538 compared with DKK 323,508 the year before. That is an increase of 45.4% compared with the year before. Equity in the 2025 report amounted to DKK 4,028,336. The solvency ratio was 82.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,380,062
- Profit/Loss
- DKK 2,278,538
- Equity
- DKK 4,028,336
- Total Assets
- DKK 4,864,329
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.4 mio. | 2.3 mio. | 4 mio. | 1 |
| 2024 | - | 949 t. | 324 t. | 1.9 mio. | 1 |
| 2023 | - | 1.7 mio. | 605 t. | 1.7 mio. | 1 |
| 2022 | - | 1.3 mio. | 258 t. | 1.2 mio. | 1 |
| 2021 | - | 997 t. | 306 t. | 1.1 mio. | 1 |
Official annual report
How creditworthy is Pharmatec Engineering ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharmatec Engineering ApS has published its annual report for 2024. Gross profit came to DKK 949,238, and the net result was DKK 323,508.
About Pharmatec Engineering ApS
Pharmatec Engineering ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kim Fasting. The company is owned by Kim Fasting. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,380,062 and a net result of DKK 2,278,538 compared with DKK 323,508 the year before. Equity in the 2025 report amounted to DKK 4,028,336.